Mar 09 (Reuters) - Editas Medicine Q4 operating expenses USD 32.496 million.
- Q4 operating income USD -7.755 million
- Q4 basic EPS USD -0.06
- Q4 EPS USD -0.06
- Q4 collaboration and other research and development revenue USD 24.7 million
Mar 09 (Reuters) - Editas Medicine Q4 operating expenses USD 32.496 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.